The Asia-Pacific perspective:
Redefining obesity and its treatment

This document has been coordinated by the International Diabetes Institute,
a World Health Organization Collaborating Centre for the Epidemiology
of Diabetes Mellitus and Health Promotion for Noncommunicable Diseases,
with an education grant from Knoll Pharmaceuticals.

Co-sponsored jointly by the Regional Office for the Western Pacific (WPRO),
World Health Organization, the International Association for the Study of Obesity
and the International Obesity Task Force.

Click Here to view the document as a Web page

Click Here to view the document as an Adobe Acrobat PDF file

BASF Pharma